Effect of continuous antistaphylococcal therapy on the rate of P. aeruginosa acquisition in patients with cystic fibrosis

Pediatric Pulmonology

Volumn 31, Issue 1, 2001, Pages 13-16

  Ratjen, F ^a   Comes, G ^a,b,c   Paul, K ^d   Posselt, H G ^a,e   Wagner, T O F ^a   Harms, K ^a,c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b IQVIA   (United States)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d GOETHE UNIVERSITY   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antibiotic therapy; Children; Colonization; Cystic fibrosis; P. aeruginosa; Staph aureus

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFACLOR; CEFALEXIN; CEFUROXIME; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN;

ADOLESCENT; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BODY MASS INDEX; CEPHALOSPORINS; CHEMOPREVENTION; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DATABASES; FORCED EXPIRATORY VOLUME; HUMANS; INFANT; LUNG; MACROLIDES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REGISTRIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VITAL CAPACITY;

EID: 0035125425     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-0496(200101)31:1<13::AID-PPUL1001>3.0.CO;2-N     Document Type: Article

References (9)

1. The changing epidemiology of cystic fibrosis
2. Antibiotic treatment of Staph. aureus infection in cystic fibrosis
3. Antibiotic prescribing practice in the UK and Eire
4. Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis
5. Treatment of Staphylococcus aureus in cystic fibrosis
6. To Keflex or not to Keflex: Long-term antibiotics in CF
7. Association between prophylactic antibiotic usage and early onset of Pseudomonas aeruginosa
8. Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period
9. Pulmonary function in infants with cystic fibrosis: The effect of antibiotic treatment